Histological assessment of non-alcoholic fatty liver disease.
about
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeMechanisms of intrahepatic triglyceride accumulationNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayIL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease ProgressionHow Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesityMultifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease.Inflammation in nonalcoholic steatohepatitis.Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment.In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopyThe relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity.Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model.Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice.Characterization of transcriptional modules related to fibrosing-NAFLD progression.High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research networkHepatic lipogranulomas in patients with chronic liver disease: association with hepatitis C and fatty liver disease.Histopathology of nonalcoholic fatty liver disease.Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.NAFLD Prevalence in a Young Cadaveric Organ Donor Population.Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fatSusceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population.Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults.Diagnosis and evaluation of nonalcoholic fatty liver disease.Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver diseaseUsefulness of the controlled attenuation parameter for detecting liver steatosis in health checkup examineesPrevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors.A chronic oral toxicity study of marine collagen peptides preparation from chum salmon (Oncorhynchus keta) skin using Sprague-Dawley ratNon-alcoholic fatty liver disease among sasang constitutional types: a population-based study in KoreaMetabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in ZebrafishRelevance of low testosterone to non-alcoholic fatty liver diseaseA case of primary clear cell hepatocellular carcinoma in a non-cirrhotic liver: an immunohistochemical and ultrastructural study.Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reductionObstructive sleep apnea with excessive daytime sleepiness is associated with non-alcoholic fatty liver disease regardless of visceral fat.Effects of lipid regulation using raw and processed radix polygoni multiflori in rats fed a high-fat diet.Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease
P2860
Q26765455-C9F2D176-E74C-4B49-BEA3-8F1805B32FC2Q26773198-DD6998CD-0E33-43F6-9491-71656FFA673DQ26800894-187BDDA1-F6F0-40BE-A507-EFCF79D3AAE7Q27025620-662AA0D8-74AD-4BAE-944A-31D69509BFBFQ28074455-DE6825C1-D21B-41A3-ABEB-85D1FFAF8D10Q28828838-3248D313-F740-400E-B4A2-4A839A65DF0EQ30371936-02159DCF-57A5-4084-9CCC-026325718B91Q30453231-9578BA6C-4C3A-4F30-9E99-CCC435270B47Q30537821-59813264-BA32-4B22-9562-762534489F0DQ31029819-AE4F2D8C-14FA-4139-AB5C-DAAE365552D9Q33550783-FAAD32F9-10BD-4311-A06A-F9ABC373625CQ33675416-25A3FFE6-47BD-4646-A2DB-3992E72BF8B5Q33863032-976F126B-103E-49FD-BC0E-16E2E059718BQ33881352-2DFBA172-6570-4835-8FD5-15B7793470E7Q34044574-E583B703-E0C6-40D0-81C9-D147AA0B0C24Q34085058-3DC30655-5C92-4E10-9E8C-1C83EA38158FQ34246954-79881CCA-B7FA-4DDC-936E-A98603A49CC6Q34306736-4789232E-899B-48CB-874D-3FB6C02F65E6Q34523876-44718AB4-4BD3-4755-ACFF-17135CD497CEQ34546142-CDB88743-C2EF-4546-BEE3-C98F99DD0B5DQ34610741-3439B43C-4D5D-4041-9C5D-C07E3F135E6CQ34618881-67F727E0-6B48-4CA1-B917-1465F53F5B3CQ34636684-15D78CA7-4C45-4F16-AEF1-96EDA2AADC8BQ34830398-FD84D738-411C-48E1-A1B0-7BDF90F86F07Q34856374-13BACDB3-4DE5-48D4-9FDC-2FC2DAA4BACEQ35018209-64911C5A-729A-4526-9399-3BC5ADA508A3Q35495753-B024716A-9BAD-4161-8889-708B7738B99EQ35550630-D86621CC-DD91-4D52-AC0E-C8B69CF58904Q35551319-49C00873-6873-4555-B163-F2639B6F9808Q35681834-F2F0F800-471C-44A6-AB6F-C687349945D9Q35759957-9466C19F-B062-40EA-9C6B-0928729CC68FQ35835264-C729E2DD-963D-40CB-A2F4-FA04F1BF07B2Q35954091-5444235C-252A-47D9-9CBB-EBD2DB0735F2Q36079305-C80F1037-A1ED-48F6-898A-C83DB4F6AD22Q36106219-3ECC50D2-B109-42AD-8B30-F263098258EBQ36261892-C20E9F66-1CD2-45DD-9FAD-F5D3416A77CAQ36272098-CB5920E8-93BB-43B3-8286-3315D401D041Q36477973-EC977115-5B8D-41C9-B287-BF995D2C425AQ36613681-EA67E44C-6C6D-449E-A380-89C9A517C25AQ36628915-BE432C4D-8B1E-40B7-97F2-8736489FAF26
P2860
Histological assessment of non-alcoholic fatty liver disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Histological assessment of non-alcoholic fatty liver disease.
@ast
Histological assessment of non-alcoholic fatty liver disease.
@en
type
label
Histological assessment of non-alcoholic fatty liver disease.
@ast
Histological assessment of non-alcoholic fatty liver disease.
@en
prefLabel
Histological assessment of non-alcoholic fatty liver disease.
@ast
Histological assessment of non-alcoholic fatty liver disease.
@en
P2860
P1433
P1476
Histological assessment of non-alcoholic fatty liver disease.
@en
P2093
Hübscher SG
P2860
P304
P356
10.1111/J.1365-2559.2006.02416.X
P577
2006-11-01T00:00:00Z